CARLOS
LOPEZ LARREA
Catedrático de Universidad
Beatriz
Tavira Iglesias
Beatriz Tavira Iglesias-rekin lankidetzan egindako argitalpenak (9)
2015
-
ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: A Next Generation Sequencing approach
Clinical Chemistry and Laboratory Medicine, Vol. 53, Núm. 10, pp. 1515-1519
-
The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients
Journal of Human Genetics, Vol. 60, Núm. 5, pp. 273-276
2013
-
A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients
Pharmacogenetics and Genomics, Vol. 23, Núm. 8, pp. 445-448
2012
-
Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus
Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527
2011
-
Erratum: Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (Clinical Chemistry and Laboratory Medicine (2011) 49:5 (825-833))
Clinical Chemistry and Laboratory Medicine
-
KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients
Clinical Transplantation, Vol. 25, Núm. 3
-
Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
Clinical Chemistry and Laboratory Medicine, Vol. 49, Núm. 5, pp. 825-833
-
Pharmacogenetics of tacrolimus: Ready for clinical translation
Kidney International Supplements, Vol. 1, Núm. 2, pp. 58-62
2010
-
Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy
Biochemical and Biophysical Research Communications, Vol. 397, Núm. 3, pp. 576-579